NCT01602666 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 107
- group Id
- BG001
- value
- 137
- group Id
- BG002
- value
- 244
- units
- Participants
- groups
- description
- Patients receive induction therapy comprising carboplatin intravenously (IV) over 15-60 minutes on day 1 and etoposide IV over 60-120 minutes on days 1-3 of courses 1, 3, and 5. Patients also receive ifosfamide IV over 60 minutes and etoposide over 60-120 minutes on days 1-5 of courses 2, 4, and 6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients achieving CR or PR undergo 3-dimensional conformal radiation therapy (3DRT) or intensity modulated radiation therapy (IMRT) once daily (QD) 5 days a week for 6 weeks. Patients with normalization of markers who fail to achieve CR or PR are strongly recommended to undergo second-look surgery. Patients who achieve CR or PR after second-look surgery undergo 3DRT or IMRT QD 5 days a week for 6 weeks.
- id
- BG000
- title
- Stratum 1 Localized Non-Germinomatous Germ Cell Tumors (NGGCT)
- description
- Patients receive induction therapy comprising carboplatin IV over 15-60 minutes on day 1 and etoposide IV over 60-120 minutes on days 1-3. Treatment repeats every 21 days for 4 courses in the absence of disease progression or unacceptable toxicity. Patients with CR or continued CR (CCR) undergo 3DRT or IMRT QD 5 days a week for 4 weeks. Patients with normalization of markers who fail to achieve CR or PR are strongly recommended to undergo second-look surgery. Patients found to have fibrosis, scar, mature teratoma, or non-viable tumor undergo 3DRT or IMRT QD 5 days a week for 4 weeks. Patients with stable disease (SD) or PR with \> 0.5 cm (suprasellar) or \> 1 cm (pineal) but =\< 1.5 cm residual disease do not undergo second-look surgery and undergo 3DRT or IMRT QD 5 days a week for 4 weeks.
- id
- BG001
- title
- Stratum 2 Localized Germinoma
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 100
- group Id
- BG001
- value
- 124
- group Id
- BG002
- value
- 224
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 20
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 3.7
- upper Limit
- 21.6
- value
- 11.0
- group Id
- BG001
- lower Limit
- 5.0
- upper Limit
- 21.5
- value
- 14.1
- group Id
- BG002
- lower Limit
- 3.7
- upper Limit
- 21.6
- value
- 13.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 64
- title
- Female
- measurements
- group Id
- BG000
- value
- 80
- group Id
- BG001
- value
- 100
- group Id
- BG002
- value
- 180
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 36
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 83
- group Id
- BG001
- value
- 113
- group Id
- BG002
- value
- 196
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 12
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 22
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 15
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 78
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 164
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 33
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 93
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 210
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 17
- title
- Australia
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- title
- New Zealand
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 107
- group Id
- BG001
- value
- 137
- group Id
- BG002
- value
- 244
- units
- Participants
- groups
- description
- Patients receive induction therapy comprising carboplatin intravenously (IV) over 15-60 minutes on day 1 and etoposide IV over 60-120 minutes on days 1-3 of courses 1, 3, and 5. Patients also receive ifosfamide IV over 60 minutes and etoposide over 60-120 minutes on days 1-5 of courses 2, 4, and 6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients achieving CR or PR undergo 3-dimensional conformal radiation therapy (3DRT) or intensity modulated radiation therapy (IMRT) once daily (QD) 5 days a week for 6 weeks. Patients with normalization of markers who fail to achieve CR or PR are strongly recommended to undergo second-look surgery. Patients who achieve CR or PR after second-look surgery undergo 3DRT or IMRT QD 5 days a week for 6 weeks.
- id
- BG000
- title
- Stratum 1 Localized Non-Germinomatous Germ Cell Tumors (NGGCT)
- description
- Patients receive induction therapy comprising carboplatin IV over 15-60 minutes on day 1 and etoposide IV over 60-120 minutes on days 1-3. Treatment repeats every 21 days for 4 courses in the absence of disease progression or unacceptable toxicity. Patients with CR or continued CR (CCR) undergo 3DRT or IMRT QD 5 days a week for 4 weeks. Patients with normalization of markers who fail to achieve CR or PR are strongly recommended to undergo second-look surgery. Patients found to have fibrosis, scar, mature teratoma, or non-viable tumor undergo 3DRT or IMRT QD 5 days a week for 4 weeks. Patients with stable disease (SD) or PR with \> 0.5 cm (suprasellar) or \> 1 cm (pineal) but =\< 1.5 cm residual disease do not undergo second-look surgery and undergo 3DRT or IMRT QD 5 days a week for 4 weeks.
- id
- BG001
- title
- Stratum 2 Localized Germinoma
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 100
- group Id
- BG001
- value
- 124
- group Id
- BG002
- value
- 224
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 20
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 3.7
- upper Limit
- 21.6
- value
- 11.0
- group Id
- BG001
- lower Limit
- 5.0
- upper Limit
- 21.5
- value
- 14.1
- group Id
- BG002
- lower Limit
- 3.7
- upper Limit
- 21.6
- value
- 13.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 64
- title
- Female
- measurements
- group Id
- BG000
- value
- 80
- group Id
- BG001
- value
- 100
- group Id
- BG002
- value
- 180
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 36
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 83
- group Id
- BG001
- value
- 113
- group Id
- BG002
- value
- 196
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 12
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 22
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 15
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 78
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 164
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 33
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 93
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 210
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 17
- title
- Australia
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- title
- New Zealand
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle